Clinical Trial Physician, Hematology at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

In-depth knowledge of etiology, natural history, diagnosis, and treatment of hematology disorders
Keeps up-to-date in the disease area via attendance at scientific conferences and ongoing review of the literature
Keeps abreast of development and regulatory issues related to competitive or relevant compounds and the competitive landscape
Broad experience in management of and participation in functional and cross-functional matrix teams
Fulfills GCP and compliance obligations for clinical conduct and maintains all required training
Strong medical/scientific reputation within the disease area

Responsibilities

Contributes to and is key member of a high performing Study Delivery Team (SDT) and Clinical Development Team (CDT)
Designs and develops clinical plans and protocols with a strong strategic focus based on knowledge of the asset/drug, disease area, and relevant science to meet regulatory and disease strategy targets
Leads the analysis of benefit/risk for clinical development protocols in a matrix team environment working in partnership with Clinical Scientists (CS)
Conducts medical data review of trial data, including eligibility review
Responsible for site interactions for medical questions and education (including safety management guidelines)
Responsible for assessment of key safety-related serious adverse events in partnership with GPVE and oversees safety narratives
Collaborates with CS on protocols, providing medical strategic oversight in protocol development (input on inclusion/exclusion criteria and other safety-related clinical considerations); signs off on protocol
Identifies and builds relationships with principal investigators; identifies and cultivates thought leaders (TLs) for inputs on emerging science, disease knowledge, and clinical development studies/programs
Provides ongoing medical education in partnership with CS, protocol-specific training to support study team, investigators, and others
Contributes to key Health Authority interactions and advisory board meetings as Clinical Trial Physician
Authors/drafts clinical content for CSRs, regulatory reports, briefing books, and submission documents to support closure, clinical narratives, reporting, and filing of the study in partnership with CSs
Reports to Clinical Development Lead (CDL)

Skills

Clinical Development

Clinical Trials

Protocol Design

Benefit/Risk Analysis

Medical Data Review

Hematology

Study Delivery Team

Clinical Development Team

Safety Management

Regulatory Strategy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free